期刊文献+

大剂量丙种球蛋白联合地塞米松治疗重度ITP疗效观察 被引量:6

Clinical of combining high dosage gamma globulin with Dexamethasone in severe ITP patients
下载PDF
导出
摘要 目的:评价大剂量丙种球蛋白联合地塞米松治疗特发性血小板减少性紫癜(ITP)的疗效。方法:将50例患者随机分为两组,联合组静滴丙种球蛋白400mg/(kg·d),连用5d,同时静滴地塞米松1.5mg/(kg·d),连用5d,第5天起口服强的松2mg/(kg·d)。地塞米松组静滴地塞米松1.5mg/(kg·d),连用5d,第5天起口服强的松2mg/(kg·d)。结果:联合组、地塞米松组使血小板计数(PLT)≥50×109/L的时间分别为(2.5±1.1)d,(5.1±1.2)d;PLT≥100×109/L的时间分别为(4.4±1.3)d,(7.8±1.5)d;达峰值时间分别为(6.9±1.2)d,(13.6±1.6)d,PLT的峰值分别为(310±102)×109/L,(160±62)×109/L。结论:大剂量丙种球蛋白联合地塞米松治疗重度ITP效果显著。 Objective: To evaluate high dosage gamma globulin with Dexamethasone in ITP patients. Methods: 50 patients were randomly divided into two groups. Joint group were given gamma globulin 400 mg/(kg.d) for 5 days, while intravenous Dexamethasone 1.5 mg/(kg.d) for 5 days, the first 5 days of oral Prednisolone 2 mg/(kg.d). Dexamethasone group were given Dexamethasone 1.5 mg/(kg.d) for 5 days, the first 5 days of oral Prednisolone 2 mg/(kg.d). Results: The time of PLT ≥50×10^9/L in the joint group and Dexamethasone group were (2.5_+1.1) days, (5.1±1.2) days; The time of PLT ≥ 100 ×10^9/L were (4.4±1.3) days, (7.8±1.5) days; peak days were (6.9±1.2) days, (13.6±1.6) days, PLT peak were (310±102)×10^9/L, (160±62)×10^9/L. Conclusion: The high dose gamma globulin combined with Dexamethasone in the treatment of severe ITP has significant effect.
作者 罗国桢
出处 《中国医药导报》 CAS 2009年第10期92-93,共2页 China Medical Herald
关键词 丙种球蛋白 地塞米松 ITP Gamma globulin Dexamethasone ITP
  • 相关文献

参考文献3

二级参考文献5

共引文献18

同被引文献44

  • 1李继英,李俐佳.以血小板减少性紫癜为前期表现的骨髓增生异常综合征1例[J].贵阳医学院学报,1996,21(3):261-261. 被引量:1
  • 2张小玲,刘跃梅,廖红群.大剂量丙种球蛋白联合地塞米松治疗急性ITP疗效分析[J].赣南医学院学报,2006,26(6):870-871. 被引量:3
  • 3McMillan R.The role of antiplatelet autoantibody assays in the diagnosis of immune thrombocytopenic purpura[J].Curr Hematol Rep,2005,4(2):160-165.
  • 4Kuwana M,Kaburaki J,Ikeda Y.Autoreactive T cells to platelet GPⅡb-Ⅲa in immune thrombocytopenic purpura.Role in production of antiplatelet autoantibody[J].J Clin Invest,1998,102(7):1393-1402.
  • 5Takahashi T,Yujiri T,Shinohara K,et al.Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H.pylori-associated chronic idiopathic thrombocytopenic purpura[J].Br J Haematol,2004,124(1):91-96.
  • 6Catani L,Fagioli ME,Tazzari PL,et al.Dendritic cells of immune thrombocytopenic purpura (ITP) show increased capacity to present apoptotic platelets to T lymphocytes[J].Exp Hematol,2006,34(7):879-887.
  • 7Kuwana M,Kawakami Y,Ikeda Y.Suppression of autoreactive T-cell response to glycoproteinⅡb /Ⅲa by blockade of CD40/CD154 interaction:implications for treatment of immune thrombocytopenic purpura[J].Blood,2003,101(2):621-623.
  • 8Nagahama M,Nomura S,Kanazawa S,et al.Significance of chemokines and soluble CD40 ligand in patients with autoimmune thrombocytopenic purpura[J].Eur J Haematol,2002,69(5/6):303-308.
  • 9Olsson B,Andersson PO,Jacobsson S,et al.Disturbed apoptosis of T-cells in patients with active idiopathic thrombocytopenic purpura[J].Thromb Haemost,2005,93(1):139-144.
  • 10Panitsas FP,Theodoropoulou M,Kouraklis A,et al.Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response[J].Blood,2004,103(7):2645-2647.

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部